J vs LPCN · P/E 36, rev $4.08B vs rev $309.5K
Jacobs Solutions Inc. (J) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
J currently screens at market cap $14.40B and trailing P/E 36.0. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the J and LPCN stock pages for the full models.
Not investment advice.